ezetimibe has been researched along with Complication, Postoperative in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (75.00) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Díaz Gómez, JM | 1 |
Castro-Beiras, A; Crespo-Leiro, MG; Flores, X; Franco, R; Grille, Z; Marzoa, R; Mosquera, V; Naya, C; Paniagua, MJ; Rodriguez, JA | 1 |
Parhofer, KG | 1 |
Arnaoutoglou, EM; Bairaktari, ET; Gartzonika, C; Kostara, C; Kouvelos, GN; Matsagkas, MI; Milionis, HJ | 1 |
Keough-Ryan, T; Kiberd, BA; Kiberd, M; Lawen, J; Puthenparumpil, JJ | 1 |
Burton, I; Koshman, SL; Lalonde, LD; Pearson, GJ; Tymchak, WJ | 1 |
Agüero, J; Almenar, L; Izquierdo, M; Martínez-Dolz, L; Moro, J; Ortiz, V; Salvador, A; Sánchez-Lazaro, I | 1 |
Heemann, U; Kohnle, M; Kribben, A; Nürnberger, J; Philipp, T; Türk, TR; Voropaeva, E; Witzke, O | 1 |
1 review(s) available for ezetimibe and Complication, Postoperative
Article | Year |
---|---|
[Cardiovascular mortality in kidney transplatation].
Topics: Anticholesteremic Agents; Azetidines; Cardiovascular Diseases; Comorbidity; Coronary Angiography; Diabetes Mellitus; Dyslipidemias; Ezetimibe; Humans; Kidney Diseases; Kidney Transplantation; Myocardial Ischemia; Obesity; Postoperative Complications; Preoperative Care; Prognosis; Risk Factors | 2008 |
4 trial(s) available for ezetimibe and Complication, Postoperative
Article | Year |
---|---|
Effects of rosuvastatin with or without ezetimibe on clinical outcomes in patients undergoing elective vascular surgery: results of a pilot study.
Topics: Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Azetidines; C-Reactive Protein; Cholesterol, LDL; Drug Therapy, Combination; Elective Surgical Procedures; Ezetimibe; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pilot Projects; Postoperative Complications; Prospective Studies; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Vascular Surgical Procedures | 2013 |
Treatment of hypercholesterolemia with ezetimibe in the kidney transplant population.
Topics: Anticholesteremic Agents; Azetidines; Cholesterol, LDL; Ezetimibe; Female; Humans; Hypercholesterolemia; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Postoperative Complications | 2005 |
Ezetimibe in heart transplantation: initial experience.
Topics: Aged; Anticholesteremic Agents; Azetidines; Cholesterol; Dyslipidemias; Ezetimibe; Female; Follow-Up Studies; Heart Transplantation; Humans; Immunosuppressive Agents; Lipids; Male; Middle Aged; Postoperative Complications; Time Factors | 2007 |
Ezetimibe treatment in hypercholesterolemic kidney transplant patients is safe and effective and reduces the decline of renal allograft function: a pilot study.
Topics: Anticholesteremic Agents; Azetidines; Case-Control Studies; Ezetimibe; Female; Humans; Hypercholesterolemia; Kidney Transplantation; Male; Middle Aged; Pilot Projects; Postoperative Complications; Prospective Studies | 2008 |
3 other study(ies) available for ezetimibe and Complication, Postoperative
Article | Year |
---|---|
The efficacy and safety of ezetimibe for treatment of dyslipidemia after heart transplantation.
Topics: Adult; Aged; Anticholesteremic Agents; Atorvastatin; Azetidines; Drug Therapy, Combination; Drug Tolerance; Dyslipidemias; Ezetimibe; Female; Heart Transplantation; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Lipids; Male; Middle Aged; Postoperative Complications; Pravastatin; Pyrroles; Young Adult | 2008 |
[After bypass surgery nearly all lipids are in the normal range. However, Lp(a) is too high, what can be done?].
Topics: Azetidines; Cholesterol; Coronary Artery Bypass; Coronary Artery Disease; Drug Therapy, Combination; Ezetimibe; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hypercholesterolemia; Hypolipidemic Agents; Indoles; Lipoprotein(a); Male; Postoperative Complications; Prognosis; Reference Values; Risk Factors; Secondary Prevention; Treatment Outcome | 2011 |
Supratherapeutic response to ezetimibe administered with cyclosporine.
Topics: Anticholesteremic Agents; Atorvastatin; Azetidines; Cyclosporine; Drug Interactions; Ezetimibe; Heart Transplantation; Heptanoic Acids; Humans; Hyperlipidemias; Immunosuppressive Agents; Male; Middle Aged; Postoperative Complications; Pyrroles | 2005 |